---
schema_version: "secwatch.filing_event.v1"
accession: "0001636422-26-000091"
form_type: "8-K"
ticker: "HCAT"
cik: "0001636422"
company_name: "Health Catalyst, Inc."
filed_at: "2026-08-06T20:09:38+00:00"
generated_at: "2026-08-06T20:12:32.332307+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Health Catalyst sells VitalWare for $147M, repays credit facility, Q2 revenue down 13%

## Summary
- Sold VitalWare to Med-Metrix for $147M cash; used proceeds plus cash on hand to fully repay $160M credit facility.
- Credit facility repayment included $122.8M term loan, $37.1M delayed draw, $3.2M prepayment premium, $0.5M accrued interest.
- Q2 2026 revenue $70.5M (down 13% YoY); net loss $40.5M (vs $41.0M loss in Q2 2025).
- Company expects to eliminate ~$19M annual GAAP interest expense from debt repayment.
- Pro forma shows VitalWare contributed $17.6M revenue in H1 2026; Health Catalyst now focuses on intelligence products.

## SEC filing metadata
- accession: 0001636422-26-000091
- form_type: 8-K
- ticker: HCAT
- cik: 0001636422
- company_name: Health Catalyst, Inc.
- filed_at: 2026-08-06T20:09:38+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.02, 2.01, 1.01, 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1636422/000163642226000091/0001636422-26-000091-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1636422/000163642226000091/hcat-20260731.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001636422-26-000091
- JSON: https://secwatch.observer/filing/0001636422-26-000091.json
- Plain text: https://secwatch.observer/filing/0001636422-26-000091.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.